Kenya aims to slash HIV in Moms-to-Be with massive PrEP rollout

NCT ID NCT06526507

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a package of tools—training for healthcare workers, quality improvement methods, and a community of practice—to help clinics in Kenya offer HIV prevention pills (PrEP) to pregnant and postpartum women. The goal is to screen more women and start them on PrEP if they want it. Over 17,000 women and healthcare workers will take part across multiple clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Implementation strategy package (training, quality improvement, community of practice)
What this could lead to
If successful, this could make HIV prevention pills more accessible to pregnant and postpartum women in Kenya, reducing new infections.
What could go wrong
This is a large-scale implementation study, not a test of a new drug. Success depends on real-world factors like staff training and clinic resources, so results may vary across settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Busia County Referral Hospital

    Busia, Kenya

  • Kapsabet County Referral Hospital

    Kapsabet, Nandi, Kenya

  • Kenyatta National Hospital

    Nairobi, MRX5 + 53, Kenya

  • Kitale County Referral Hospital

    Kitale, Trans Nzoia, Kenya

  • Uasin Gishu District Hospital

    Eldoret, Uasin Gishu County, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.